AG
PAHC icon

Advisor Group’s Phibro Animal Health PAHC Stock Holding History

Advisor Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$35K Sell
1,389
-224
-14% -$5.2K ﹤0.01% 3649
2019
Q3 		$35K Sell
1,613
-746
-32% -$20.4K ﹤0.01% 3632
2019
Q2 		$75K Sell
2,359
-237
-9% -$7.43K ﹤0.01% 3084
2019
Q1 		$85K Buy
2,596
+745
+40% +$23.2K ﹤0.01% 2998
2018
Q4 		$60K Sell
1,851
-180
-9% -$6.79K ﹤0.01% 3053
2018
Q3 		$87K Buy
2,031
+376
+23% +$17.8K ﹤0.01% 2859
2018
Q2 		$76K Buy
1,655
+439
+36% +$19.4K ﹤0.01% 2752
2018
Q1 		$48K Sell
1,216
-251
-17% -$9.3K ﹤0.01% 3093
2017
Q4 		$49K Buy
1,467
+1,104
+304% +$39.2K ﹤0.01% 3097
2017
Q3 		$13K Sell
363
-198
-35% -$7.43K ﹤0.01% 3825
2017
Q2 		$21K Sell
561
-80
-12% -$2.61K ﹤0.01% 3479
2017
Q1 		$18K Buy
641
+122
+24% +$3.44K ﹤0.01% 3438
2016
Q4 		$15K Buy
519
+373
+255% +$10.2K ﹤0.01% 3399
2016
Q3 		$4K Buy
146
+47
+47% +$1.06K ﹤0.01% 3988
2016
Q2 		$1K Buy
+99
New +$2.06K ﹤0.01% 4257

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisor Group's PAHC Position: Q4 2019 in Review

Advisor Group reduced its Phibro Animal Health (PAHC) stake by 14% in Q4 2019, selling an estimated $5.2K and leaving 1,389 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #3649.

Advisor Group first reported a position in PAHC in Q2 2016 and has held it in 15 quarters since. The position peaked at $87K in Q3 2018. 155 funds tracked by Wall St. Rank hold PAHC as of Q4 2019.

  • Advisor Group held 1,389 shares of Phibro Animal Health worth $35K as of Q4 2019.
  • Advisor Group sold 224 Phibro Animal Health shares in Q4 2019, an estimated $5.2K.
  • Phibro Animal Health made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3649 holding.
  • Advisor Group first reported a position in Phibro Animal Health in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Phibro Animal Health position peaked at $87K in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.